Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7966 AL 7980

New Research on Biomarkers in Alzheimer's Continuum

Vecchio I, Colica C.

Rev Recent Clin Trials. 2025;20(3):211-231. doi: 10.2174/0115748871331138250114052615.

Alzheimer's disease: assessing the therapeutic potential of anti-Aβ (Beta-Amyloid) treatments

Almutairi JA.

Cell Mol Biol (Noisy-le-grand). 2025 Feb 2;71(1):111-117. doi: 10.14715/cmb/2025.70.1.12.

Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China

Leng L, Liao Z, Lu P, Sun Y, Weng Q, Fan W, Zhu H, Wu W, Liu P, Liu X, Zhang K, Wang W, Luo B, Wang Z, Peng G.

J Alzheimers Dis. 2026 Feb;109(3):1346-1356. doi: 10.1177/13872877251406619. Epub 2025 Dec 15.

The Role of Blood-Based Biomarkers in Transforming Alzheimer's Disease Research and Clinical Management: A Review

Pacoova Dal Maschio V, Roveta F, Bonino L, Boschi S, Rainero I, Rubino E.

Int J Mol Sci. 2025 Sep 3;26(17):8564. doi: 10.3390/ijms26178564.

Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer's disease

Shaw S, Porel P, Aran KR.

Mol Biol Rep. 2025 Apr 8;52(1):370. doi: 10.1007/s11033-025-10485-4.

Atypical Alzheimer's dementia: Addressing the subtypes, epidemiology, atypical presentations, diagnostic biomarkers, and treatment updates

Vora N, Patel P, Marsool MDM, Marsool ADM, Sunasra R, Ladani P, Pati S, Khoont D, Prajjwal P, Ranjan R.

Dis Mon. 2025 May;71(5):101863. doi: 10.1016/j.disamonth.2025.101863. Epub 2025 Feb 1.

Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study

Wang S, Xi J, Zhang M, Wang J.

Int J Biol Macromol. 2025 Mar;294:139394. doi: 10.1016/j.ijbiomac.2024.139394. Epub 2025 Jan 3.

The challenging concept of preclinical Alzheimer's disease

Wallon D, Garnier-Crussard A.

Rev Neurol (Paris). 2025 Nov;181(9):881-892. doi: 10.1016/j.neurol.2025.07.016. Epub 2025 Nov 12.

The Biomarker Profile of Alzheimer's Disease for Disease-Modifying Treatment Eligibility: Questions and Debates

Athanasaki A, Tsantzali I, Theodorou A, Michalopoulou A, Constantinides VC, Boufidou F, Tzartos JS, Tsalouchidou PE, Zompola C, Paraskevas SG, Bonakis A, Giannopoulos S, Tsivgoulis G, Kapaki E, Paraskevas GP.

Int J Mol Sci. 2025 Sep 29;26(19):9531. doi: 10.3390/ijms26199531.

The Inflammatory Nexus: Unraveling Shared Pathways and Promising Treatments in Alzheimer's Disease and Schizophrenia

Russo AP, Pastorello Y, Dénes L, Brînzaniuc K, Krupinski J, Slevin M.

Int J Mol Sci. 2025 Jun 27;26(13):6237. doi: 10.3390/ijms26136237.

Unlocking the Future of Alzheimer's Disease: Innovations in Diagnosis and Therapy

Mehndiratta MM, Singla M, Dixit A.

J Assoc Physicians India. 2025 Aug;73(8):92-97. doi: 10.59556/japi.73.1075.

The roles of biomarkers in Alzheimer's disease clinical trials

Cummings J, Sharma S, DeAndrea G, Osse AL, Ortiz A.

Neurotherapeutics. 2026 Jan;23(1):e00811. doi: 10.1016/j.neurot.2025.e00811. Epub 2025 Dec 24.

The impact of real-world evidence in implementing and optimizing Alzheimer's disease care

Hampel H, Li G, Mielke MM, Galvin JE, Kivipelto M, Santarnecchi E, Babiloni C, Devanarayan V, Tkatch R, Hu Y, Kurzman R, Cho M, Vandercappellen J, Nakamura Y, Bell J, Mattke S, Toschi N.

Med. 2025 May 9;6(5):100695. doi: 10.1016/j.medj.2025.100695.

Clinical use of biomarkers in the era of Alzheimer's disease treatments

VandeVrede L, Schindler SE.

Alzheimers Dement. 2025 Jan;21(1):e14201. doi: 10.1002/alz.14201. Epub 2024 Dec 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias